NAME

Jun Ren

Paper Publications

Functionalized Magnetic Fe3O4-beta-Cyclodextran Nanoparticles for Efficient Removal of Bilirubin
  • Hits:
  • Indexed by:

    期刊论文

  • First Author:

    Han, Lulu

  • Correspondence Author:

    Jia, LY (reprint author), Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian 116023, Liaoning, Peoples R China.

  • Co-author:

    Chu, Simin,Wei, Houliang,Ren, Jun,Xu, Li,Jia, Lingyun

  • Date of Publication:

    2016-06-01

  • Journal:

    JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY

  • Included Journals:

    SCIE、EI

  • Document Type:

    J

  • Volume:

    16

  • Issue:

    6

  • Page Number:

    5537-5545

  • ISSN No.:

    1533-4880

  • Key Words:

    Magnetic Nanoparticles; beta-Cyclodextran; Bilirubin; Adsorbent; Removal

  • Abstract:

    Bilirubin (BR), as a lipophilic toxin, can binds and deposits in various tissues, especially the brain tissue, leading to hepatic coma and even death. Magnetic nanoparticles adsorbent modified by beta-cyclodextran (Fe3O4-beta-CD) was developed to remove the BR from the plasma. Fe3O4-beta-CD nanoparticles was prepared through Schiff base reaction between the polyethylenimine (PEI)modified Fe3O4 and aldehyde-functionalized beta-CD, and characterized by Fourier transform infrared (FTIR) spectra, X-ray diffraction (XRD), transmission electron microscopy (TEM), vibrating sample magnetometer (VSM) and dynamic light scattering (DLS). Under optimized conditions, the Fe3O4-beta-CD adsorbent could adsorb 225.6 mg/g free BR in PBS and reach the adsorption equilibrium within 90 min mainly through hydrophobic interaction. Moreover, the adsorbent displayed better adsorption capability in a dialysis system for BSA-bound bilirubin, plasma bilirubin and total bile acid, and the removal rates of those were 66%, 31% and 41% respectively. Because of the advantages of fast separation and purification process, low preparation cost, good adsorption capability for plasma bilirubin, Fe3O4-beta-CD may become an economical and promising absorbent of BR for clinical applications.

Pre One:一种重组蛋白A的定点固定化方法

Next One:Direct site-specific immobilization of protein A viaaldehyde-hydrazide conjugation